世界の上皮成長因子受容体（EGFR）阻害薬市場は、予測期間中に約8.6 %のCAGRで推移し、2022年から2026年の間に67億5,000万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。
本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場は、主要な癌の適応症の高有病率、意識向上キャンペーン、および研究資金によって推進されています。 さらに、主要な癌の適応症の高有病率は、市場の成長も後押しすると予想されます。
本調査では、今後数年間の上皮成長因子受容体（EGFR）阻害薬市場の成長を牽引する主要な理由の一つとして、新たな研究分野を挙げています。また、新しい研究分野、強力なパイプライン、償還制度の増加が、市場の大きな需要につながるでしょう。
Technavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要な上皮成長因子受容体（EGFR）阻害薬市場ベンダーの詳細な分析を提供します
この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。
TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。
目次
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Indication
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Indication
5.1 Market segments
Exhibit 24: Chart on Indication - Market share 2021-2026 (%)
Exhibit 25: Data Table on Indication - Market share 2021-2026 (%)
5.2 Comparison by Indication
Exhibit 26: Chart on Comparison by Indication
Exhibit 27: Data Table on Comparison by Indication
5.3 Lung cancer - Market size and forecast 2021-2026
Exhibit 28: Chart on Lung cancer - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Lung cancer - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Lung cancer - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Lung cancer - Year-over-year growth 2021-2026 (%)
5.4 Colorectal cancer - Market size and forecast 2021-2026
Exhibit 32: Chart on Colorectal cancer - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Colorectal cancer - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Colorectal cancer - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Colorectal cancer - Year-over-year growth 2021-2026 (%)
5.5 Breast cancer - Market size and forecast 2021-2026
Exhibit 36: Chart on Breast cancer - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Breast cancer - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Breast cancer - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Breast cancer - Year-over-year growth 2021-2026 (%)
5.6 Others - Market size and forecast 2021-2026
Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Indication
Exhibit 44: Market opportunity by Indication ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 Canada - Market size and forecast 2021-2026
Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.11 France - Market size and forecast 2021-2026
Exhibit 82: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on France - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 86: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 Amgen Inc.
Exhibit 93: Amgen Inc. - Overview
Exhibit 94: Amgen Inc. - Product / Service
Exhibit 95: Amgen Inc. - Key offerings
10.4 Apollomics Inc.
Exhibit 96: Apollomics Inc. - Overview
Exhibit 97: Apollomics Inc. - Product / Service
Exhibit 98: Apollomics Inc. - Key news
Exhibit 99: Apollomics Inc. - Key offerings
10.5 AstraZeneca Plc
Exhibit 100: AstraZeneca Plc - Overview
Exhibit 101: AstraZeneca Plc - Product / Service
Exhibit 102: AstraZeneca Plc - Key news
Exhibit 103: AstraZeneca Plc - Key offerings
10.6 Boehringer Ingelheim International GmbH
Exhibit 104: Boehringer Ingelheim International GmbH - Overview
Exhibit 105: Boehringer Ingelheim International GmbH - Business segments
Exhibit 106: Boehringer Ingelheim International GmbH - Key news
Exhibit 107: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 108: Boehringer Ingelheim International GmbH - Segment focus
10.7 Checkpoint Therapeutics Inc.
Exhibit 109: Checkpoint Therapeutics Inc. - Overview
Exhibit 110: Checkpoint Therapeutics Inc. - Business segments
Exhibit 111: Checkpoint Therapeutics Inc. - Key offerings
Exhibit 112: Checkpoint Therapeutics Inc. - Segment focus
10.8 Eli Lilly and Co.
Exhibit 113: Eli Lilly and Co. - Overview
Exhibit 114: Eli Lilly and Co. - Business segments
Exhibit 115: Eli Lilly and Co. - Key offerings
Exhibit 116: Eli Lilly and Co. - Segment focus
10.9 F. Hoffmann La Roche Ltd.
Exhibit 117: F. Hoffmann La Roche Ltd. - Overview
Exhibit 118: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 119: F. Hoffmann La Roche Ltd. - Key news
Exhibit 120: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 121: F. Hoffmann La Roche Ltd. - Segment focus
10.10 Novartis AG
Exhibit 122: Novartis AG - Overview
Exhibit 123: Novartis AG - Business segments
Exhibit 124: Novartis AG - Key offerings
Exhibit 125: Novartis AG - Segment focus
10.11 Pfizer Inc.
Exhibit 126: Pfizer Inc. - Overview
Exhibit 127: Pfizer Inc. - Product / Service
Exhibit 128: Pfizer Inc. - Key news
Exhibit 129: Pfizer Inc. - Key offerings
10.12 Puma Biotechnology Inc.
Exhibit 130: Puma Biotechnology Inc. - Overview
Exhibit 131: Puma Biotechnology Inc. - Business segments
Exhibit 132: Puma Biotechnology Inc. - Key news
Exhibit 133: Puma Biotechnology Inc. - Key offerings
Exhibit 134: Puma Biotechnology Inc. - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 135: Inclusions checklist
Exhibit 136: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 137: Currency conversion rates for US$
11.4 Research methodology
Exhibit 138: Research methodology
Exhibit 139: Validation techniques employed for market sizing
Exhibit 140: Information sources
11.5 List of abbreviations
Exhibit 141: List of abbreviations
Exhibits
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Indication
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Indication - Market share 2021-2026 (%)
Exhibits25: Data Table on Indication - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Indication
Exhibits27: Data Table on Comparison by Indication
Exhibits28: Chart on Lung cancer - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Lung cancer - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Lung cancer - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Lung cancer - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Colorectal cancer - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Colorectal cancer - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Colorectal cancer - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Colorectal cancer - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Breast cancer - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Breast cancer - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Breast cancer - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Breast cancer - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Indication ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: Amgen Inc. - Overview
Exhibits94: Amgen Inc. - Product / Service
Exhibits95: Amgen Inc. - Key offerings
Exhibits96: Apollomics Inc. - Overview
Exhibits97: Apollomics Inc. - Product / Service
Exhibits98: Apollomics Inc. - Key news
Exhibits99: Apollomics Inc. - Key offerings
Exhibits100: AstraZeneca Plc - Overview
Exhibits101: AstraZeneca Plc - Product / Service
Exhibits102: AstraZeneca Plc - Key news
Exhibits103: AstraZeneca Plc - Key offerings
Exhibits104: Boehringer Ingelheim International GmbH - Overview
Exhibits105: Boehringer Ingelheim International GmbH - Business segments
Exhibits106: Boehringer Ingelheim International GmbH - Key news
Exhibits107: Boehringer Ingelheim International GmbH - Key offerings
Exhibits108: Boehringer Ingelheim International GmbH - Segment focus
Exhibits109: Checkpoint Therapeutics Inc. - Overview
Exhibits110: Checkpoint Therapeutics Inc. - Business segments
Exhibits111: Checkpoint Therapeutics Inc. - Key offerings
Exhibits112: Checkpoint Therapeutics Inc. - Segment focus
Exhibits113: Eli Lilly and Co. - Overview
Exhibits114: Eli Lilly and Co. - Business segments
Exhibits115: Eli Lilly and Co. - Key offerings
Exhibits116: Eli Lilly and Co. - Segment focus
Exhibits117: F. Hoffmann La Roche Ltd. - Overview
Exhibits118: F. Hoffmann La Roche Ltd. - Business segments
Exhibits119: F. Hoffmann La Roche Ltd. - Key news
Exhibits120: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits121: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits122: Novartis AG - Overview
Exhibits123: Novartis AG - Business segments
Exhibits124: Novartis AG - Key offerings
Exhibits125: Novartis AG - Segment focus
Exhibits126: Pfizer Inc. - Overview
Exhibits127: Pfizer Inc. - Product / Service
Exhibits128: Pfizer Inc. - Key news
Exhibits129: Pfizer Inc. - Key offerings
Exhibits130: Puma Biotechnology Inc. - Overview
Exhibits131: Puma Biotechnology Inc. - Business segments
Exhibits132: Puma Biotechnology Inc. - Key news
Exhibits133: Puma Biotechnology Inc. - Key offerings
Exhibits134: Puma Biotechnology Inc. - Segment focus
Exhibits135: Inclusions checklist
Exhibits136: Exclusions checklist
Exhibits137: Currency conversion rates for US$
Exhibits138: Research methodology
Exhibits139: Validation techniques employed for market sizing
Exhibits140: Information sources
Exhibits141: List of abbreviations
